BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31537468)

  • 1. Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.
    Yuan X; Rosenberg JT; Liu Y; Grant SC; Ma T
    Cytotherapy; 2019 Oct; 21(10):1033-1048. PubMed ID: 31537468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
    Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.
    Horita Y; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    J Neurosci Res; 2006 Nov; 84(7):1495-504. PubMed ID: 16998918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Parametric Response Mapping to Assess Therapeutic Response to Human Mesenchymal Stem Cells after Experimental Stroke.
    He R; Moisan A; Detante O; Rémy C; Krainik A; Barbier EL; Lemasson B
    Cell Transplant; 2017 Aug; 26(8):1462-1471. PubMed ID: 28901185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats.
    Yan T; Venkat P; Chopp M; Zacharek A; Ning R; Roberts C; Zhang Y; Lu M; Chen J
    Stroke; 2016 Nov; 47(11):2850-2858. PubMed ID: 27729575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.
    Moon GJ; Cho YH; Kim DH; Sung JH; Son JP; Kim S; Cha JM; Bang OY
    Cell Transplant; 2018 Mar; 27(3):485-500. PubMed ID: 29774769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study.
    Moisan A; Pannetier N; Grillon E; Richard MJ; de Fraipont F; Rémy C; Barbier EL; Detante O
    NMR Biomed; 2012 Dec; 25(12):1340-8. PubMed ID: 22539476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia.
    Onda T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):329-40. PubMed ID: 17637706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model.
    Choi C; Kim HM; Shon J; Park J; Kim HT; Kang SH; Oh SH; Kim NK; Kim OJ
    Cytotherapy; 2018 Jun; 20(6):820-829. PubMed ID: 29776835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
    Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
    Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate.
    Tsai AC; Liu Y; Yuan X; Ma T
    Tissue Eng Part A; 2015 May; 21(9-10):1705-19. PubMed ID: 25661745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells.
    Oh SH; Choi C; Chang DJ; Shin DA; Lee N; Jeon I; Sung JH; Lee H; Hong KS; Ko JJ; Song J
    Cytotherapy; 2015 Aug; 17(8):1090-103. PubMed ID: 26031742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.
    Yamaguchi S; Horie N; Satoh K; Ishikawa T; Mori T; Maeda H; Fukuda Y; Ishizaka S; Hiu T; Morofuji Y; Izumo T; Nishida N; Matsuo T
    J Cereb Blood Flow Metab; 2018 Jul; 38(7):1199-1212. PubMed ID: 28914133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.
    Omori Y; Honmou O; Harada K; Suzuki J; Houkin K; Kocsis JD
    Brain Res; 2008 Oct; 1236():30-8. PubMed ID: 18722359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinuclear MRI Reveals Early Efficacy of Stem Cell Therapy in Stroke.
    Helsper S; Yuan X; Bagdasarian FA; Athey J; Li Y; Borlongan CV; Grant SC
    Transl Stroke Res; 2023 Aug; 14(4):545-561. PubMed ID: 35900719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.
    Li Y; Chen J; Chen XG; Wang L; Gautam SC; Xu YX; Katakowski M; Zhang LJ; Lu M; Janakiraman N; Chopp M
    Neurology; 2002 Aug; 59(4):514-23. PubMed ID: 12196642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution.
    Detante O; Moisan A; Dimastromatteo J; Richard MJ; Riou L; Grillon E; Barbier E; Desruet MD; De Fraipont F; Segebarth C; Jaillard A; Hommel M; Ghezzi C; Remy C
    Cell Transplant; 2009; 18(12):1369-79. PubMed ID: 19849895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia.
    Steiner B; Roch M; Holtkamp N; Kurtz A
    Neurosci Lett; 2012 Mar; 513(1):25-30. PubMed ID: 22342911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo.
    Jiang W; Liang G; Li X; Li Z; Gao X; Feng S; Wang X; Liu M; Liu Y
    J Mater Sci Mater Med; 2014 May; 25(5):1357-66. PubMed ID: 24469290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.